Skip to main content
. 2022 Jun 1;13:847605. doi: 10.3389/fphar.2022.847605

FIGURE 5.

FIGURE 5

KPT-8602 suppresses LPS-induced systemic inflammation. (A) C57BL/6 mice were given LPS (10 mg/kg) intraperitoneally after oral admiration of KPT-8602 (5 mg/kg) or vehicle (5 mice per group). (B) Representative photomicrographs of paraffin-embedded sections of the liver, lung, and kidney tissues stained with H&E. Scale bars, 250 μm for images, respectively. The expression levels of IL-1β, IL-6, and iNOS in the liver (C) and lung (D) were detected by real-time PCR. The expression of NLRP3, pro-caspase-1, pro-IL-1β, cleaved caspase-1, cleaved-IL-1β, and β-actin in the liver was analyzed by Western blotting (E), and the gray values of their bands were analyzed by using ImageJ and were normalized to β-actin (F). (* indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001 by one-way ANOVA).